Optimizing the Management of Plaque Psoriasis: A Focus on IL-23 Inhibitors
Evaluation

Questions marked with a * are required

33%

Contact Information

First Name

Last Name

Email Address

Credentials/Degree (MD, DO, RN, etc.)

Date of Participation

What is your job role?

Dermatology

Family Medicine

Internal Medicine

Nurse Practitioner

Physician Assistant

Other

What is your type of practice?

Hospital

Academic

Community/Private

HMO/MCO

Other

How many years have you been in practice?

Less than 5

5 to 9

10 to 15

More than 15

N/A

Please estimate the number of patients with plaque psoriasis that you provide for weekly:

1 to 10

11 to 25

26 to 50

51 to 75

76 to 100

101 to 125

126 to 150

More Than 150

N/A

Were the following learning objectives met? Please check appropriate rating

	Strongly Agree	Agree	Neutral	Disgaree	Strongly Disagree
Assess patients with plaque psoriasis for disease severity and response to therapy	Strongly Agree	Agree	Neutral	Disgaree	Strongly Disagree

Compare the benefits and risks of IL-23 inhibitors with other biologics for the management of plaque psoriasis	Strongly Agree	Agree	Neutral	Disgaree	Strongly Disagree

Incorporate evidence-based research and guidelines into the selection of treatment options	Strongly Agree	Agree	Neutral	Disgaree	Strongly Disagree